Cargando…

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium

In a blinded phase 1 trial (EudraCT 2017-0000908-21; NCT03430349) in Belgium, healthy adults (aged 18–50 years) previously immunized exclusively with inactivated poliovirus vaccine were administered a single dose of 1 of 2 novel type 2 oral poliovirus vaccines (nOPV2-c1: S2/cre5/S15domV/rec1/hifi3 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brickley, Elizabeth B, Connor, Ruth I, Wieland-Alter, Wendy, Weiner, Joshua A, Ackerman, Margaret E, Arita, Minetaro, Gast, Chris, De Coster, Ilse, Van Damme, Pierre, Bandyopadhyay, Ananda S, Wright, Peter F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400418/ https://www.ncbi.nlm.nih.gov/pubmed/33367918 http://dx.doi.org/10.1093/infdis/jiaa783

Ejemplares similares

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
por: Wright, Peter F, et al.
Publicado: (2016)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Essential Domains of Oxysterol-Binding Protein Required for Poliovirus Replication
por: Arita, Minetaro
Publicado: (2022)

Characterization of Anti-Poliovirus Compounds Isolated from Edible Plants
por: Arita, Minetaro, et al.
Publicado: (2023)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2019)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
por: Van Damme, Pierre, et al.
Publicado: (2019)

Evaluation of Direct Detection Protocols for Poliovirus from Stool Samples of Acute Flaccid Paralysis Patients
por: Ueno, Minami Kikuchi, et al.
Publicado: (2023)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection( )
por: Wright, Peter F, et al.
Publicado: (2022)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
por: Yeh, Ming Te, et al.
Publicado: (2020)

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study
por: Erdem, Rahsan, et al.
Publicado: (2023)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials
por: Wahid, Rahnuma, et al.
Publicado: (2022)

The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016–2019
por: Gray, Elizabeth J, et al.
Publicado: (2023)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus
por: Matrajt, Graciela, et al.
Publicado: (2018)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
por: Butler, Savannah E., et al.
Publicado: (2021)

High-Order Epistasis and Functional Coupling of Infection Steps Drive Virus Evolution toward Independence from a Host Pathway
por: Arita, Minetaro
Publicado: (2021)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
por: Davlantes, Elizabeth, et al.
Publicado: (2023)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2019)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

AN ALUMINUM MARKER FOR THE DIFFERENTIATION AND SEPARATION OF VIRULENT AND ATTENUATED POLIOVIRUSES
por: Wallis, Craig, et al.
Publicado: (1962)

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
por: Cooper, Laura V, et al.
Publicado: (2022)

Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021()
por: Snider, Cynthia J., et al.
Publicado: (2023)

BIOLOGICAL PROPERTIES OF RIBONUCLEIC ACID FROM VIRULENT AND ATTENUATED POLIOVIRUS
por: Gerber, Paul, et al.
Publicado: (1960)

INFECTIVITY OF RIBONUCLEIC ACID FROM POLIOVIRUS IN HUMAN CELL MONOLAYERS
por: Alexander, Hattie E., et al.
Publicado: (1958)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Wahid, Rahnuma, et al.
Publicado: (2021)

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
por: Crowley, Andrew R., et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal()
por: Harutyunyan, Vachagan, et al.
Publicado: (2023)

Antiviral Activity of Sulfated Polysaccharide of Adenanthera pavonina against Poliovirus in HEp-2 Cells
por: de Godoi, Ananda Marques, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dfc3m33khfvmo7ur49qtpf8rhp